Osorio Ana, Barroso Alicia, García Maria J, Martínez-Delgado Beatriz, Urioste Miguel, Benítez Javier
Group of Human Genetics, Human Cancer Genetics Programme, c/Melchor Fernández Almagro 3, Madrid, 28029, Spain.
Breast Cancer Res Treat. 2009 Jan;113(2):371-6. doi: 10.1007/s10549-008-9933-4. Epub 2008 Feb 13.
RAP80 and CCDC98 have arisen as new candidate breast cancer susceptibility genes, since they encode for two very recently identified BRCA1 interacting proteins. In this study we have performed the first mutational analysis of both genes in 168 multiple-case breast/ovarian cancer families, negative for mutations in BRCA1 or BRCA2. We have not found truncating mutations in any of the genes and only two missense variants, p.Tyr564His in RAP80, and p.Met299Ile in CCDC98 were found that could be suspected to have a pathogenic effect, although further analyses suggested that they were probably non deleterious. Our analysis suggests that RAP80 and CCDC98 do not play an important role as high penetrance breast cancer susceptibility genes.
RAP80和CCDC98已成为新的乳腺癌易感基因候选者,因为它们编码两种最近才鉴定出的与BRCA1相互作用的蛋白质。在本研究中,我们对168个多病例乳腺癌/卵巢癌家族中的这两个基因进行了首次突变分析,这些家族中BRCA1或BRCA2均无突变。我们在任何一个基因中都未发现截短突变,仅发现两个错义变体,即RAP80中的p.Tyr564His和CCDC98中的p.Met299Ile,可能被怀疑具有致病作用,尽管进一步分析表明它们可能无害。我们的分析表明,RAP80和CCDC98作为高外显率乳腺癌易感基因并不起重要作用。